Preclinical Services | Drug Safety & Efficacy Studies | Charles River

preclinical services 

Charles River has the proven experience, range of services and expertise to help you successfully initiate and complete critical phases of preclinical drug development by designing, performing and documenting safety tests that meet the appropriate regulatory requirements before and after clinical trials begin. Our scientific and regulatory staff are committed to providing exactly what you need with flexible solutions, accelerated timelines and customized approaches. For your IND-enabling program proposal, click here.

Charles River’s preclinical newsletter, the Researcher, contains detailed information designed to support your research. These publications are now available online through our information portal, The Source.

To register for The Source, please click here.
Already registered?  Please click here to login.



Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
mai 14 - New Models for Evaluating COPD or ...
mai 11 - Expert Safety Testing to Accelerat...
juin 17-juin 20 -  Noordwijk aan Zee, the Netherlands - 19th MDO Meeting / 12th Europea...
juin 02-juin 05 - Vancouver, British Columbia - CALAS
juin 05-juin 05 - King of Prussia, Pennsylvania - Assessment of Immunomodulation for Bi...
juin 05-juin 08 - Saint Germain sur l’Arbresle, France - Charles River LAL Seminar Seri...
view all
RMS Specialist Montreal, Canada

Charles River Laboratories, Inc.